Skip to main content
. Author manuscript; available in PMC: 2016 May 15.
Published in final edited form as: Cancer. 2015 Jan 29;121(10):1645–1653. doi: 10.1002/cncr.29224

Table 1.

Demographic information on patients enrolled.

Demographic Result
Total Enrolled 22

Age – mean (range) years 62 (37 – 83)

Gender – male/female 9 / 13

Primary Disease
  Colorectal 8
  Lung (total) 8
    Adenocarcinoma 4
    Squamous cell 3
    Other 1
  Anal 2
  Head and Neck 4

Lines of Chemotherapy for Metastatic/Recurrent Disease – mean (range) 3.6 (1 – 11)

Prior anti-EGFR therapy 13 (59%)

cetuximab 8

Erlotinib 2

  Multiple anti-EGFR agents 3